Role of protein tyrosine phosphatases in T cell activation

Immunological Reviews

Volumn 191, Issue , 2003, Pages 139-147

  Mustelin, Tomas ^a   Rahmouni, Souad ^a   Bottini, Nunzio ^a   Alonso, Andres ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD45; AUTOIMMUNE DISEASES; HUMANS; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0037304929     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2003.00014.x     Document Type: Review

References (83)

1. Mustelin T, Coggeshall KM, Isakov N, Altman A. Tyrosine phosphorylation is required for T cell antigen receptor-mediated activation of phospholipase C. Science 1990;247:1584-1587.
2. June C, et al. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc Natl Acad Sci USA 1990;87:7722-7727.
3. Klausner RD, Samelson LE. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell 1991;64:875-878.
4. Mustelin T, Abraham RT, Rudd CE, Alonso A, Merlo JJ. Protein tyrosine phosphorylation in T cell signaling. Front Biosci 2002;7:918-969.
5. Mustelin T, Burn P. Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem Sci 1993;18:215-220.
6. Mustelin T. T cell antigen receptor signaling: three families of tyrosine kinases and a phosphatase. Immunity 1994; 1: 351-356.
7. van Leeuwen JE, Samelson LE. T cell antigen-receptor signal transduction. Curr Opin Immunol 1999;11:242-248.
8. Mustelin T. Src Family Tyrosine Kinases in Leukocytes. Austin, TX: R. G. Landes Co, 1994.
9. García-Morales P, Minami Y, Luong ET, Klansner RD, Samelson LE. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide. Proc Natl Acad Sci USA 1990;87:9255-9259.
10. lck protein tyrosine kinase by phenylarsine oxide, a phosphotyrosine phosphatase inhibitor. Mol Immunol 1994;31:1295-1302.
11. O'Shea JJ, McVivar DW, Bailey TL, Burns C, Smyth MJ. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci USA 1992;89:10306-10310.
12. Secrist JP, Burns LA, Karnitz L, Koretzky GA, Abraham RT. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J Biol Chem 1993;268:5886-5893.
13. Iivanainen AV, Lindqvist C, Mustelin T, Andersson LC. Phosphotyrosine phosphatases are involved in reversion of T lymphoblastic proliferation. Eur J Immunol 1990;10:2509-2512.
14. Mustelin T. Keeping the T cell immune response in balance; role of protein tyrosine phosphatases in autoimmunity. In: Altman A, ed. Current Directions on Autoimmunity, Vol. 5. New York: Karger Press, 2002:176-190.
15. Mustelin T, et al. T cell activation: the coming of the phosphatases. Front Biosci 1998;3:1060-1096.
16. Mustelin T, et al. The next wave: protein tyrosine phosphatases enter T cell antigen receptor signaling. Cell Signal 1999;11:637-650.
17. Mustelin T, et al. Protein tyrosine phosphatases. Front Biosci 2002;7:85-14-2.
18. Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995;155:2269-2281.
19. Liossis SN, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor ζ chain. J Clin Invest 1998;101:1448-1457.
20. Tsokos GC, Liossis SN. Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999;20:119-124.
21. Gjôrloff-Wingren A, et al. Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur J Immunol 2000;30:2412-2421.
22. Mustelin T, Hunter T. Meeting at mitosis. Cell cycle-specific regulation of c-Src by RPTPα. Science's STKE. 2002. http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;2002/115/pe3.
23. Tailor P, Williams S, Gilman J, Couture C, Mustelin T. Regulation of the low molecular weight phosphotyrosine phosphatase (LMPTP) by phosphorylation at tyrosines 131 and 132. J Biol Chem 1997;272:5371-5376.
24. Alonso A, et al. Tyrosine phosphorylation of VHR phosphatase by ZAP-70. Nat Immunol 2003;4:44-48.
25. Charbonneau H, et al. Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 1989;86:5252-5256.
26. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol 1989;7:339-369.
27. Tonks NK, Charbonneau H, Diltz CD, Fischer EH, Walsh KA. Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 1988;27:8695-8701.
28. lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci USA 1989;86:6502-6306.
29. Pingel JT, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 1989;58:1055-1065.
30. Koretzky GA, Picus J, Thomas ML, Weiss A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 1990;346:66-68.
31. 2+ oscillations. J Exp Med 1992;176: 835-844.
32. Ostergaard HL, et al. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci USA 1989;86:8959-8963.
33. lck by the leukocyte common antigen (CD45). Oncogene 1990;5:809-813.
34. fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur J Immunol 1992;22:1173-1178.
35. fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx. EMBO J 1992;11:4887-4897.
36. Sieh M, Bolen JB, Weiss A. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J 1993;12:315-321.
37. Hurley TR, Hyman R, Sefton BM. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn and c-src tyrosine protein kinases. Mol Cell Biol 1993;13:1651-1656.
38. Turka LA, Kanner SB, Schieven GL, Thompson CB, Ledbetter JA. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phos-phorylation. Eur J Immunol 1992;22: 551-557.
39. Cahir McFarland ED, Hurley TR, Pingel JT, Sefton BM, Shaw A, Thomas ML. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci USA 1993;90:1402-1406.
40. Irie-Sasaki J, et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001;409:349-354.
41. Shenoi H, Seavitt J, Zheleznyak A, Thomas M, Brown E. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J Immunol 1999;162:7120-7127.
42. Byth KF, et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development in the selection of CD4+CD8+ thymocytes and B-cell maturation. J Exp Med 1996;183:1707-1718.
43. Wallace VA, et al. Alterations in the level of CD45 surface expression affect the outcome of thymic selection. J Immunol 1997;158:3205-3214.
44. lck Y505F mutation in CD45-deficient mice rescues thymocyte development. Mol Cell Biol 1999;19:4200-4208.
45. Alonso A, Saxena M, Williams S, Mustelln T. Inhibitory role for dual-specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J Biol Chem 2001;276:4766-4771.
46. Alonso A, et al. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR). J Biol Chem 2002;277:5524-5528.
47. Saxena M, Williams S, Gilman J, Mustelin T. Negative regulation of T cell antigen receptor signaling by hematopoietic tyrosine phosphatase (HePTP). J Biol Chem 1998;273:15340-15344.
48. Saxena M, Williams S, Brockdorff J, Gilman J, Mustelin T. Inhibition of T cell signaling by MAP kinase-targeted hematopoietic tyrosine phosphatase (HePTP). J Biol Chem 1999;274:11693-11700.
49. Saxena M, Williams S, Taskén K, Mustelin T. Crosstalk between cAMP-dependent kinase and MAP kinase through hematopoietic protein tyrosine phosphatase (HePTP). Nat Cell Biol 1999;1:305-311.
50. Gjörloff-Wingren A, Saxena M, Williams S, Hammi D, Mustelin T. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol 1999;29:3845-3854.
51. Han S, Williams S, Mustelin T. Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling. Eur J Immunol 2000;30:1318-1325.
52. Brockdorff J, Williams S, Couture C, Mustelin T. Dephosphorylation of ZAP-70 and inhibition of T cell activation by activated SHP1. Eur J Immunol 1999;29:2539-2550.
53. Bottini N, et al. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002;277:24220-24224.
54. Matthews RJ, Bowne DB, Flores E, Thomas M. Characterization of hematopoietic intracellular protein tyrosine phosphatases. Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992;12:2396-2405.
55. Roy G, Matthews J, Woodford-Thomas T, Thomas ML. The function of protein tyrosine phosphatases in immune regulation. Adv Protein Phosphatases 1995;9:121-138.
56. Cloutier J, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999;189:111-121.
57. csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J 1996;15:4909-4918.
58. csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J Biol Chem 1997;272:23455-23462.
59. cas as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol Cell Biol 1996;16:6408-6418.
60. Cote JF, Charest A, Wagner J, Tremblay ML. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model. Biochemistry 1998;37:13128-13137.
61. Davidson D, Veillette A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J 2001;20:3414-3426.
62. Vivier E, Daëron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997;18:286-291.
63. Pani G, Fischer K-D, Mlinaric-Rascan I, Siminovitch KA. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med 1996;184:839-852.
64. Feng GS. Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res 1999;253:47-54.
65. Gu H, Pratt JC, Burakoff SJ, Neel BG. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell 1998;2:729-740.
66. Nishida K, et al. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood 1999;93:1809-1816.
67. Brockdorff J, et al. Gab2 is tyrosine phosphorylated upon IL-2/IL-15 stimulation in mycosis fungoides derived tumor T cells and associates inducibly with SHP-2 and Stat5a. Exp Clin Immunogenet 2001;18:86-95.
68. Frearson JA, Alexander DR. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. J Exp Med 1998;187:1417-1426.
69. Qu C, Nguyen S, Chen J, Feng GS. Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood 2001;97:911-914.
70. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999;93:2013-2024.
71. Zhang S-H, Liu J, Kobayashi R, Tonks NK. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J Biol Chem 1999;274: 17806-17812.
72. Egerton M, Ashe OR, Chen D, Druker BJ, Burgess WH, Samelson LE. VCP, the mammalian homolog of CDC48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J 1992;11:3533-3540.
73. Sato T, Irie S, Kitada S, Reed JC. PAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-415.
74. Saxena M, Mustelin T. Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol 2000;12:387-396.
75. Gronda M, Arab S, Iafrate B, Suzuki H, Zanke B. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Mol Cell Biol 2001;21:6851-6858.
76. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 1996;13:925-931.
77. Wang X, et al. Enlargement of secretory vesicles by protein tyrosine phosphatase PTP-MEG2 in RBL mast cells and Jurkat T cells. J Immunol 2002;168:4612-4619.
78. Zhu W, Mustelin T, David M. Arginine methylation of STAT1 regulates its dephosphorylation by TcPTP. J Biol Chem 2002;277:35787-35790.
79. Brdicka T, et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation. J Exp Med 2000;191:1591-1604.
80. Torgersen KM, et al. Release from tonic inhibition of T cell activation through transient displacement of c-terminal Src kinase (Csk) from lipid rafts. J Biol Chem 2001;276:29313-29318.
81. Vang T, et al. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 2001;193:497-507.
82. Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988;9:222-225.
83. Skålhegg BS, Tasken K, Hansson V, Huitfeldt HS, Jahnsen T, Lea T. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 1994;263:84-87.